Estrogen Does Not Prevent Recurrent Strokes
Despite some past evidence that hormone replacement might lower stroke risk in older women, new research shows that estrogen therapy does not protect women from recurrent strokes and may instead carry some risks. The findings add to growing evidence that hormone replacement therapy does not have the cardiovascular benefits doctors once believed. // Many doctors have long thought hormo...Radiation Therapy An Effective Solution For Recurrent Prostate Cancer
Specialists say about 30,000 men in the United States who undergo surgery to have their prostates removed will have their cancer return.// However a recent study shows that men who have their prostates removed may benefit from radiation therapy if their cancer returns . Researchers studied more than 500 men with prostate cancer. All the men in the study first had a radical prostatectomy...Prevention Of Recurrent Leg Ulcers
Latest research shows that combination treatment proves to be the best option to substantially reduce the risk of recurrent leg ulcers.// Surgery to remove part of the affected vein in addition to compression treatment was investigated as a new treatment option for leg ulcers .Surgery did not present any additional benefit in terms of venous ulcer healing, but recurrence rates were sign...Heparin does not protect from recurrent heart attacks
Professor Mahaffey and his team from Duke Clinical Research Institute have found that either form of heparin (both low molecular weight and unfractionated)gives emergency// protection to heart attack patients by breaking the clots in blood flow to the heart reducing the risk of heart attacks for 24 hours. Though both the forms of heparin gives emergency treatment they are not found to avoid the r...Measuring Urinary Protein Helps In Detecting Recurrent Bladder Cancer
Recurrent bladder cancer can be detected through measuring a certain protein present in the urine. Where the US is concerned, bladder cancer is reported to be the fifth most malignant, which recorded 63,210 new cases in the year 2005 //year alone, with over 13,000 deaths. The country has a total of 500,000 patients with a bladder cancer history, and the chances of its recurrence is between 50% an...Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
Phase II GBM study presented at ASCO with cediranib - a selectiveVEGF signaling inhibitor - shows over a quarter of patients aliveand progression- free at six months(1) CHICAGO, June 04, 2007 /PRNewswire/ -- Data for theinvestigational agent cediranib (AZD2171) were presented today atthe annual meeting of the American Society of Clinical Oncology(ASCO) from a study in patients with recurr...